Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,975,156
in 10 filings, $2.0M under 10b5-1 plans

Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-23 CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO Grant or award +54,470 117,615
2021-03-23 Lalwani Nikhil PRESIDENT & CEO Grant or award +136,495 165,003
2021-03-23 Pera Antonio R Director Grant or award +9,292 16,713
2021-03-23 Thoma Jeanne Director Grant or award +9,292 16,713
2021-03-23 NASH DAVID Director Grant or award +9,292 21,647
2021-03-23 HAUGHEY THOMAS Director Grant or award +9,292 27,702
2021-03-23 Brown Robert E. JR Director Grant or award +9,292 38,972
2021-03-23 Walsh Patrick D Director Grant or award +9,292 48,388
2021-03-15 Walsh Patrick D Director Purchase +4,000 $32.89 $132K 39,096
2021-02-15 Mutz Christopher CHIEF COMMERCIAL OFFICER Grant or award +16,134 16,134
2021-02-15 Mutz Christopher CHIEF COMMERCIAL OFFICER Grant or award · Stock Option (right to buy) +33,758 33,758
2021-02-15 Gutwerg Ori SVP, GENERICS Grant or award +12,907 12,907
2021-02-15 Gutwerg Ori SVP, GENERICS Grant or award · Stock Option (right to buy) +27,006 27,006
2020-11-09 Walsh Patrick D Director Purchase +5,000 $25.96 $130K 35,096
2020-09-08 Lalwani Nikhil PRESIDENT & CEO Grant or award +28,508 28,508
2020-09-08 Lalwani Nikhil PRESIDENT & CEO Grant or award · Stock Option (right to buy) +179,643 179,643
2020-08-10 Walsh Patrick D CHAIRMAN, INTERIM PRES. & CEO Purchase +3,000 $30.40 $91K 23,096
2020-08-10 Walsh Patrick D CHAIRMAN, INTERIM PRES. & CEO Purchase +4,000 $30.98 $124K 27,096
2020-08-10 Walsh Patrick D CHAIRMAN, INTERIM PRES. & CEO Purchase +3,000 $30.89 $93K 30,096
2020-08-05 Pera Antonio R Director Grant or award +7,421 7,421

Page 25 of 31 · 601 trades